Search

Your search keyword '"Indoleamine-Pyrrole 2"' showing total 4 results

Search Constraints

Start Over You searched for: Descriptor "Indoleamine-Pyrrole 2" Remove constraint Descriptor: "Indoleamine-Pyrrole 2" Journal journal for immunotherapy of cancer Remove constraint Journal: journal for immunotherapy of cancer
4 results on '"Indoleamine-Pyrrole 2"'

Search Results

1. Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma

2. GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape

3. Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma.

4. GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.

Catalog

Books, media, physical & digital resources